{"transactions":[{"id":713895,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":31774,"kind":"person","name":"Spencer John","position":1,"cik":"0002144116","reported_name":"Spencer John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-07T21:51:02.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":55900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. One fifth of the options vest on the grant date and the remainder of the options subsequently vest in equal annual installments over the first, second, third and fourth anniversary of the grant date upon the continued performance of services by the Reporting Person to the Company through the vesting dates. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":55900,"derivative":{"exercise_price":0.59,"expiration_date":"2036-07-01","underlying":"Common Stock","underlying_shares":55900},"source":{"system":"sec-edgar","filing":"0002144116-26-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000214411626000005/primary_doc.xml","form_type":"4"}},{"id":933589,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2026-01-22T18:04:30.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":125000,"derivative":{"exercise_price":0.93,"exercise_date":"2025-12-11","expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001382225-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000138222526000001/primary_doc.xml","form_type":"4/A","original_submission_date":"2025-12-15"}},{"id":933588,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-22T18:04:30.000Z","date":"2025-12-12","kind":"sale","planned":false,"acquired":false,"shares":210,"price":0.9446,"value":198.366,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.9440 to $0.9451. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Amendment is being filed to correct the amount of securities beneficially owned. The Issuer effected a 1-for-30 reverse stock split of its outstanding common stock, which was not reflected on the prior Form 4."}],"balance_after":948,"source":{"system":"sec-edgar","filing":"0001382225-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000138222526000001/primary_doc.xml","form_type":"4/A","original_submission_date":"2025-12-15"}},{"id":969825,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71586,"kind":"person","name":"Huffman Janet","position":1,"cik":"0001866284","reported_name":"Huffman Janet","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-15T21:55:39.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. One third of the options vest on the first anniversary of the grant date and the remainder of the options subsequently vest in equal annual installments over the second and third anniversary of the grant date upon the continued performance of services by the Reporting Person to the Company through the vesting dates. The option exercise price is the Company's closing price on the date of grant."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. One third of the options vest on the first anniversary of the grant date and the remainder of the options subsequently vest in equal annual installments over the second and third anniversary of the grant date upon the continued performance of services by the Reporting Person to the Company through the vesting dates. The option exercise price is the Company's closing price on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. One third of the options vest on the first anniversary of the grant date and the remainder of the options subsequently vest in equal annual installments over the second and third anniversary of the grant date upon the continued performance of services by the Reporting Person to the Company through the vesting dates. The option exercise price is the Company's closing price on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. One third of the options vest on the first anniversary of the grant date and the remainder of the options subsequently vest in equal annual installments over the second and third anniversary of the grant date upon the continued performance of services by the Reporting Person to the Company through the vesting dates. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":250000,"derivative":{"exercise_price":0.93,"expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001866284-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000186628425000002/primary_doc.xml","form_type":"4"}},{"id":969824,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71585,"kind":"person","name":"Giordano Natasha","position":1,"cik":"0001315585","reported_name":"Giordano Natasha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2025-12-15T21:49:15.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":125000,"derivative":{"exercise_price":0.93,"exercise_date":"2025-12-11","expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001315585-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000131558525000003/primary_doc.xml","form_type":"4"}},{"id":969823,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71585,"kind":"person","name":"Giordano Natasha","position":1,"cik":"0001315585","reported_name":"Giordano Natasha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2025-12-15T21:49:15.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":38320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an initial equity award upon appointment to the Company's board of directors (the \"Board\") of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately. The option exercise price is the Company's closing price on the date immediately prior to the reporting person's appointment to the Company's Board. The Board granted the options on December 11, 2025."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an initial equity award upon appointment to the Company's board of directors (the \"Board\") of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately. The option exercise price is the Company's closing price on the date immediately prior to the reporting person's appointment to the Company's Board. The Board granted the options on December 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an initial equity award upon appointment to the Company's board of directors (the \"Board\") of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately. The option exercise price is the Company's closing price on the date immediately prior to the reporting person's appointment to the Company's Board. The Board granted the options on December 11, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an initial equity award upon appointment to the Company's board of directors (the \"Board\") of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately. The option exercise price is the Company's closing price on the date immediately prior to the reporting person's appointment to the Company's Board. The Board granted the options on December 11, 2025."}],"balance_after":38320,"derivative":{"exercise_price":1.03,"exercise_date":"2025-12-11","expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":38320},"source":{"system":"sec-edgar","filing":"0001315585-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000131558525000003/primary_doc.xml","form_type":"4"}},{"id":969821,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2025-12-15T21:38:38.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":125000,"derivative":{"exercise_price":0.93,"exercise_date":"2025-12-11","expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001382225-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000138222525000002/primary_doc.xml","form_type":"4"}},{"id":969820,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-15T21:38:38.000Z","date":"2025-12-12","kind":"sale","planned":false,"acquired":false,"shares":210,"price":0.9446,"value":198.366,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions ranging from $0.9440 to $0.9451. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":34538,"source":{"system":"sec-edgar","filing":"0001382225-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000138222525000002/primary_doc.xml","form_type":"4"}},{"id":969822,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71584,"kind":"person","name":"GANDOLFO JOHN P","position":1,"cik":"0001200155","reported_name":"GANDOLFO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2025-12-15T21:31:35.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":125000,"derivative":{"exercise_price":0.93,"exercise_date":"2025-12-11","expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001200155-25-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000120015525000004/primary_doc.xml","form_type":"4"}},{"id":969819,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":26392,"kind":"person","name":"DUNTON ALAN W","position":1,"cik":"0001304773","reported_name":"DUNTON ALAN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2025-12-15T21:25:37.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":125000,"derivative":{"exercise_price":0.93,"exercise_date":"2025-12-11","expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001304773-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000130477325000003/primary_doc.xml","form_type":"4"}},{"id":969818,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71583,"kind":"person","name":"KOSKI ROBERT C","position":1,"cik":"0001234880","reported_name":"KOSKI ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2025-12-15T21:19:51.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":125000,"derivative":{"exercise_price":0.93,"exercise_date":"2025-12-11","expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001234880-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000123488025000002/primary_doc.xml","form_type":"4"}},{"id":969942,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71592,"kind":"person","name":"POPE CHARLES L","position":1,"cik":"0001136354","reported_name":"POPE CHARLES L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2025-12-15T16:12:58.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":125000,"derivative":{"exercise_price":0.93,"exercise_date":"2025-12-11","expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001136354-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136354/000113635425000002/primary_doc.xml","form_type":"4"}},{"id":1106674,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":8618,"kind":"organization","name":"Odyssey Health, Inc.","position":1,"cik":"0001626644","reported_name":"Odyssey Health, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock - OGEN","published_at":"2025-06-18T21:10:06.000Z","date":"2025-06-18","kind":"sale","planned":false,"acquired":false,"shares":5044,"price":4.26,"value":21487.44,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001683168-25-004612","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000168316825004612/ownership.xml","form_type":"4"}},{"id":1106673,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":8618,"kind":"organization","name":"Odyssey Health, Inc.","position":1,"cik":"0001626644","reported_name":"Odyssey Health, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock - OGEN","published_at":"2025-06-18T21:10:06.000Z","date":"2025-06-17","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":4.46,"value":8920.0,"ownership":{"direct":true},"balance_after":5044,"source":{"system":"sec-edgar","filing":"0001683168-25-004612","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000168316825004612/ownership.xml","form_type":"4"}},{"id":1110151,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":8618,"kind":"organization","name":"Odyssey Health, Inc.","position":1,"cik":"0001626644","reported_name":"Odyssey Health, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock - OGEN","published_at":"2025-06-16T22:01:26.000Z","date":"2025-06-16","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":4.45,"value":22250.0,"ownership":{"direct":true},"balance_after":7044,"source":{"system":"sec-edgar","filing":"0001683168-25-004526","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000168316825004526/ownership.xml","form_type":"4"}},{"id":1110150,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":8618,"kind":"organization","name":"Odyssey Health, Inc.","position":1,"cik":"0001626644","reported_name":"Odyssey Health, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock - OGEN","published_at":"2025-06-16T22:01:26.000Z","date":"2025-06-13","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":4.27,"value":21350.0,"ownership":{"direct":true},"balance_after":12044,"source":{"system":"sec-edgar","filing":"0001683168-25-004526","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000168316825004526/ownership.xml","form_type":"4"}},{"id":1332720,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71583,"kind":"person","name":"KOSKI ROBERT C","position":1,"cik":"0001234880","reported_name":"KOSKI ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2024-12-13T21:05:15.000Z","date":"2024-12-11","kind":"exercise","planned":false,"acquired":false,"shares":1500000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series B was convertible into common stock at any time and had no expiration date. The Series B was issued on November 8, 2017, with an original issue price of $0.50 per share. On January 19, 2018, the Issuer effected a 1-for-10 reverse stock split, and on January 20, 2023, the Issuer effected a one-for-sixty reverse stock split, which collectively resulted in an adjusted conversion price of $300.00 per share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series B was convertible into common stock at any time and had no expiration date. The Series B was issued on November 8, 2017, with an original issue price of $0.50 per share. On January 19, 2018, the Issuer effected a 1-for-10 reverse stock split, and on January 20, 2023, the Issuer effected a one-for-sixty reverse stock split, which collectively resulted in an adjusted conversion price of $300.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series B was convertible into common stock at any time and had no expiration date. The Series B was issued on November 8, 2017, with an original issue price of $0.50 per share. On January 19, 2018, the Issuer effected a 1-for-10 reverse stock split, and on January 20, 2023, the Issuer effected a one-for-sixty reverse stock split, which collectively resulted in an adjusted conversion price of $300.00 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series B was convertible into common stock at any time and had no expiration date. The Series B was issued on November 8, 2017, with an original issue price of $0.50 per share. On January 19, 2018, the Issuer effected a 1-for-10 reverse stock split, and on January 20, 2023, the Issuer effected a one-for-sixty reverse stock split, which collectively resulted in an adjusted conversion price of $300.00 per share."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Represents the full conversion of Series B Convertible Preferred Stock (\"Series B\") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents shares owned by the Koski Family Limited Partnership (\"KFLP\"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-24-049989","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224049989/ownership.xml","form_type":"4"}},{"id":1332719,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71583,"kind":"person","name":"KOSKI ROBERT C","position":1,"cik":"0001234880","reported_name":"KOSKI ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-13T21:05:15.000Z","date":"2024-12-11","kind":"exercise","planned":false,"acquired":true,"shares":5000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares owned by the Koski Family Limited Partnership (\"KFLP\"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the full conversion of Series B Convertible Preferred Stock (\"Series B\") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares owned by the Koski Family Limited Partnership (\"KFLP\"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the full conversion of Series B Convertible Preferred Stock (\"Series B\") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series B was convertible into common stock at any time and had no expiration date. The Series B was issued on November 8, 2017, with an original issue price of $0.50 per share. On January 19, 2018, the Issuer effected a 1-for-10 reverse stock split, and on January 20, 2023, the Issuer effected a one-for-sixty reverse stock split, which collectively resulted in an adjusted conversion price of $300.00 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents shares owned by the Koski Family Limited Partnership (\"KFLP\"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents the full conversion of Series B Convertible Preferred Stock (\"Series B\") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Represents shares owned by the Koski Family Limited Partnership (\"KFLP\"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Represents the full conversion of Series B Convertible Preferred Stock (\"Series B\") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents shares owned by the Koski Family Limited Partnership (\"KFLP\"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents the full conversion of Series B Convertible Preferred Stock (\"Series B\") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B."}],"balance_after":23367,"source":{"system":"sec-edgar","filing":"0001493152-24-049989","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224049989/ownership.xml","form_type":"4"}},{"id":1339327,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":26392,"kind":"person","name":"DUNTON ALAN W","position":1,"cik":"0001304773","reported_name":"DUNTON ALAN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-09T23:07:35.000Z","date":"2024-12-06","kind":"sale","planned":false,"acquired":false,"shares":66,"price":0.36,"value":23.76,"ownership":{"direct":true},"balance_after":25623,"source":{"system":"sec-edgar","filing":"0001493152-24-049325","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224049325/ownership.xml","form_type":"4"}},{"id":1339326,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-09T21:23:29.000Z","date":"2024-12-06","kind":"sale","planned":false,"acquired":false,"shares":3597,"price":0.36,"value":1294.92,"ownership":{"direct":true},"balance_after":34748,"source":{"system":"sec-edgar","filing":"0001493152-24-049278","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224049278/ownership.xml","form_type":"4"}},{"id":1401798,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71586,"kind":"person","name":"Huffman Janet","position":1,"cik":"0001866284","reported_name":"Huffman Janet","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Option (Right to Buy)","published_at":"2024-09-21T01:15:53.000Z","date":"2024-09-19","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. The option shares vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. The option shares vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. The option shares vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. The option shares vest immediately. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":80000,"derivative":{"exercise_price":0.48,"exercise_date":"2024-09-19","expiration_date":"2034-09-19","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001493152-24-037730","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224037730/ownership.xml","form_type":"4"}},{"id":1401797,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":87345,"kind":"person","name":"REDMOND J MICHAEL","position":1,"cik":"0001200166","reported_name":"REDMOND J MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Option (Right to Buy)","published_at":"2024-09-21T01:15:52.000Z","date":"2024-09-19","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. The option shares vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. The option shares vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. The option shares vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. The option shares vest immediately. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":100000,"derivative":{"exercise_price":0.48,"exercise_date":"2024-09-19","expiration_date":"2034-09-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-24-037733","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224037733/ownership.xml","form_type":"4"}},{"id":1401796,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71584,"kind":"person","name":"GANDOLFO JOHN P","position":1,"cik":"0001200155","reported_name":"GANDOLFO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2024-09-21T01:15:49.000Z","date":"2024-09-19","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":45000,"derivative":{"exercise_price":0.48,"exercise_date":"2024-09-19","expiration_date":"2034-09-19","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001493152-24-037729","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224037729/ownership.xml","form_type":"4"}},{"id":1401795,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":26392,"kind":"person","name":"DUNTON ALAN W","position":1,"cik":"0001304773","reported_name":"DUNTON ALAN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2024-09-21T01:15:48.000Z","date":"2024-09-19","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":65000,"derivative":{"exercise_price":0.48,"exercise_date":"2024-09-19","expiration_date":"2034-09-19","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001493152-24-037728","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224037728/ownership.xml","form_type":"4"}},{"id":1401794,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71583,"kind":"person","name":"KOSKI ROBERT C","position":1,"cik":"0001234880","reported_name":"KOSKI ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2024-09-21T01:15:47.000Z","date":"2024-09-19","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":65000,"derivative":{"exercise_price":0.48,"exercise_date":"2024-09-19","expiration_date":"2034-09-19","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001493152-24-037731","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224037731/ownership.xml","form_type":"4"}},{"id":1401793,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":81902,"kind":"person","name":"Cassidy Bruce A. Sr.","position":1,"cik":"0001484879","reported_name":"Cassidy Bruce A. Sr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2024-09-21T01:15:46.000Z","date":"2024-09-19","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":45000,"derivative":{"exercise_price":0.48,"exercise_date":"2024-09-19","expiration_date":"2034-09-19","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001493152-24-037727","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224037727/ownership.xml","form_type":"4"}},{"id":1401792,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":87344,"kind":"person","name":"Murphy Kimberly M","position":1,"cik":"0001810474","reported_name":"Murphy Kimberly M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2024-09-21T01:15:44.000Z","date":"2024-09-19","kind":"grant","planned":false,"acquired":true,"shares":27083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":27083,"derivative":{"exercise_price":0.48,"exercise_date":"2024-09-19","expiration_date":"2034-09-19","underlying":"Common Stock","underlying_shares":27083},"source":{"system":"sec-edgar","filing":"0001493152-24-037726","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224037726/ownership.xml","form_type":"4"}},{"id":1401791,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2024-09-21T01:15:43.000Z","date":"2024-09-19","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":65000,"derivative":{"exercise_price":0.48,"exercise_date":"2024-09-19","expiration_date":"2034-09-19","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001493152-24-037734","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224037734/ownership.xml","form_type":"4"}},{"id":1401803,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71592,"kind":"person","name":"POPE CHARLES L","position":1,"cik":"0001136354","reported_name":"POPE CHARLES L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2024-09-20T21:15:50.000Z","date":"2024-09-19","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":100000,"derivative":{"exercise_price":0.48,"exercise_date":"2024-09-19","expiration_date":"2034-09-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-24-037732","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136354/000149315224037732/ownership.xml","form_type":"4"}},{"id":1674391,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71583,"kind":"person","name":"KOSKI ROBERT C","position":1,"cik":"0001234880","reported_name":"KOSKI ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-22T22:30:15.000Z","date":"2023-08-08","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 5 is being filed by the Reporting Person to correct an administrative error, which incorrectly reported the number of shares of Common Stock as beneficially owned by the Reporting Person."}],"balance_after":27940,"source":{"system":"sec-edgar","filing":"0001493152-24-003332","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224003332/ownership.xml","form_type":"5"}},{"id":1696767,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":87345,"kind":"person","name":"REDMOND J MICHAEL","position":1,"cik":"0001200166","reported_name":"REDMOND J MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Option (Right to Buy)","published_at":"2024-01-02T22:09:29.000Z","date":"2023-12-28","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, in connection with the Reporting Person's engagement to serve as the Company's President. 37,500 options shall vest on the December 28, 2023, the effective date of the Reporting Person's Employment Agreement with the Company (the \"Effective Date\"), 18,750 options shall vest on June 24, 2024, and 18,750 options shall vest on the first anniversary of the Effective Date, in each case provided the Reporting Person has remained in continuous employment with the Company through such dates. The option exercise price is the Company's closing price on the date of grant."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, in connection with the Reporting Person's engagement to serve as the Company's President. 37,500 options shall vest on the December 28, 2023, the effective date of the Reporting Person's Employment Agreement with the Company (the \"Effective Date\"), 18,750 options shall vest on June 24, 2024, and 18,750 options shall vest on the first anniversary of the Effective Date, in each case provided the Reporting Person has remained in continuous employment with the Company through such dates. The option exercise price is the Company's closing price on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, in connection with the Reporting Person's engagement to serve as the Company's President. 37,500 options shall vest on the December 28, 2023, the effective date of the Reporting Person's Employment Agreement with the Company (the \"Effective Date\"), 18,750 options shall vest on June 24, 2024, and 18,750 options shall vest on the first anniversary of the Effective Date, in each case provided the Reporting Person has remained in continuous employment with the Company through such dates. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":75000,"derivative":{"exercise_price":5.4,"expiration_date":"2033-12-28","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-24-000124","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224000124/ownership.xml","form_type":"4"}},{"id":1725716,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-01T22:23:19.000Z","date":"2023-11-30","kind":"sale","planned":false,"acquired":false,"shares":3500,"price":3.5681,"value":12488.35,"ownership":{"direct":true},"balance_after":38345,"source":{"system":"sec-edgar","filing":"0001493152-23-043456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315223043456/ownership.xml","form_type":"4"}},{"id":1763846,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71584,"kind":"person","name":"GANDOLFO JOHN P","position":1,"cik":"0001200155","reported_name":"GANDOLFO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2023-10-06T20:33:35.000Z","date":"2023-10-04","kind":"grant","planned":false,"acquired":true,"shares":5102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an initial equity award upon appointment to the Company's board of directors of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an initial equity award upon appointment to the Company's board of directors of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an initial equity award upon appointment to the Company's board of directors of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately."}],"balance_after":5102,"derivative":{"exercise_price":2.94,"expiration_date":"2033-10-04","underlying":"Common Stock","underlying_shares":5102},"source":{"system":"sec-edgar","filing":"0001493152-23-036522","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315223036522/ownership.xml","form_type":"4"}},{"id":1763845,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":81902,"kind":"person","name":"Cassidy Bruce A. Sr.","position":1,"cik":"0001484879","reported_name":"Cassidy Bruce A. Sr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2023-10-06T20:31:28.000Z","date":"2023-10-04","kind":"grant","planned":false,"acquired":true,"shares":5102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an initial equity award upon appointment to the Company's board of directors of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an initial equity award upon appointment to the Company's board of directors of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an initial equity award upon appointment to the Company's board of directors of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately."}],"balance_after":5102,"derivative":{"exercise_price":2.94,"expiration_date":"2033-10-04","underlying":"Common Stock","underlying_shares":5102},"source":{"system":"sec-edgar","filing":"0001493152-23-036519","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315223036519/ownership.xml","form_type":"4"}},{"id":1811066,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71583,"kind":"person","name":"KOSKI ROBERT C","position":1,"cik":"0001234880","reported_name":"KOSKI ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-10T20:30:35.000Z","date":"2023-08-08","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock pursuant to the Company's non-employee director compensation program under the Company's 2021 Equity Incentive Plan with 20,000 shares vesting immediately and 5,000 shares vesting in six (6) months."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects adjustments made in connection with the 1-for-60 reverse stock split of the Issuer's common stock which became effective on January 23, 2023."}],"balance_after":25689,"source":{"system":"sec-edgar","filing":"0001493152-23-027579","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315223027579/ownership.xml","form_type":"4"}},{"id":1811067,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":87344,"kind":"person","name":"Murphy Kimberly M","position":1,"cik":"0001810474","reported_name":"Murphy Kimberly M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-08-10T20:30:31.000Z","date":"2023-08-08","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock of the Company's common stock under the Company's 2021 Equity Incentive Plan in connection with serving as the Company President and Chief Executive Officer with 20,000 shares vesting immediately and 5,000 shares vesting in six (6) months."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001493152-23-027580","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315223027580/ownership.xml","form_type":"4"}},{"id":1811065,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":26392,"kind":"person","name":"DUNTON ALAN W","position":1,"cik":"0001304773","reported_name":"DUNTON ALAN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-10T20:30:28.000Z","date":"2023-08-08","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock pursuant to the Company's non-employee director compensation program under the Company's 2021 Equity Incentive Plan with 20,000 shares vesting immediately and 5,000 shares vesting in six (6) months."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects adjustments made in connection with the 1-for-60 reverse stock split of the Issuer's common stock which became effective on January 23, 2023"}],"balance_after":25689,"source":{"system":"sec-edgar","filing":"0001493152-23-027577","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315223027577/ownership.xml","form_type":"4"}},{"id":1811064,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71586,"kind":"person","name":"Huffman Janet","position":1,"cik":"0001866284","reported_name":"Huffman Janet","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"Common Stock","published_at":"2023-08-10T20:30:25.000Z","date":"2023-08-08","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock of the Company's common stock under the Company's 2021 Equity Incentive Plan in connection with serving as the Company Secretary, Treasurer and Chief Financial Officer with 10,000 shares vesting immediately and 5,000 shares vesting in six (6) months."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001493152-23-027578","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315223027578/ownership.xml","form_type":"4"}},{"id":1811063,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-10T20:30:22.000Z","date":"2023-08-08","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock pursuant to the Company's non-employee director compensation program under the Company's 2021 Equity Incentive Plan with 20,000 shares vesting immediately and 5,000 shares vesting in six (6) months."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects adjustments made in connection with the 1-for-60 reverse stock split of the Issuer's common stock which became effective on January 23, 2023"}],"balance_after":41845,"source":{"system":"sec-edgar","filing":"0001493152-23-027582","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315223027582/ownership.xml","form_type":"4"}},{"id":1811076,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71592,"kind":"person","name":"POPE CHARLES L","position":1,"cik":"0001136354","reported_name":"POPE CHARLES L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-10T16:30:34.000Z","date":"2023-08-08","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock pursuant to the Company's non-employee director compensation program under the Company's 2021 Equity Incentive Plan with 20,000 shares vesting immediately and 5,000 shares vesting in six (6) months."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects adjustments made in connection with the 1-for-60 reverse stock split of the Issuer's common stock which became effective on January 23, 2023."}],"balance_after":25471,"source":{"system":"sec-edgar","filing":"0001493152-23-027581","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136354/000149315223027581/ownership.xml","form_type":"4"}},{"id":1963708,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71586,"kind":"person","name":"Huffman Janet","position":1,"cik":"0001866284","reported_name":"Huffman Janet","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"Employee Option (Right to Buy)","published_at":"2023-03-08T21:31:44.000Z","date":"2023-03-07","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan in connection with the engagement to serve as the Company's Chief Financial Officer. The options vest as follows: 1,400 options vest on the grant date, 1,400 options vest on September 7, 2023, 1,400 options vest on March 7, 2024, 1,400 options vest on September 7, 2024, and 1,400 options vest on March 7, 2025. The option exercise price is the Company's closing price on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan in connection with the engagement to serve as the Company's Chief Financial Officer. The options vest as follows: 1,400 options vest on the grant date, 1,400 options vest on September 7, 2023, 1,400 options vest on March 7, 2024, 1,400 options vest on September 7, 2024, and 1,400 options vest on March 7, 2025. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":7000,"derivative":{"exercise_price":4,"exercise_date":"2023-03-07","expiration_date":"2033-03-07","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001493152-23-007010","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315223007010/ownership.xml","form_type":"4"}},{"id":2072958,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71583,"kind":"person","name":"KOSKI ROBERT C","position":1,"cik":"0001234880","reported_name":"KOSKI ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-03T21:20:22.000Z","date":"2022-12-30","kind":"sale","acquired":false,"shares":42357,"price":0.1055,"value":4468.6635,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The prices reported in Column 4 were the weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1020 to $0.1121 and $0.1026 to $0.1096 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares owned by the Koski Family Limited Partnership (\"KFLP\"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose."}],"balance_after":1102295,"source":{"system":"sec-edgar","filing":"0001493152-23-000130","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315223000130/ownership.xml","form_type":"4"}},{"id":2072957,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71583,"kind":"person","name":"KOSKI ROBERT C","position":1,"cik":"0001234880","reported_name":"KOSKI ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-03T21:20:22.000Z","date":"2022-12-29","kind":"sale","acquired":false,"shares":36648,"price":0.106,"value":3884.688,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The prices reported in Column 4 were the weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1020 to $0.1121 and $0.1026 to $0.1096 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares owned directly by Robert C. Koski, a director of the Company."}],"balance_after":176191,"source":{"system":"sec-edgar","filing":"0001493152-23-000130","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315223000130/ownership.xml","form_type":"4"}},{"id":2084074,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71583,"kind":"person","name":"KOSKI ROBERT C","position":1,"cik":"0001234880","reported_name":"KOSKI ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-16T21:05:41.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":140497,"price":0.1758,"value":24699.3726,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The prices reported in Column 4 were the weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1700 to $0.1800 and $0.1600 to $0.1800 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares owned by the Koski Family Limited Partnership (\"KFLP\"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose."}],"balance_after":1144652,"source":{"system":"sec-edgar","filing":"0001493152-22-035732","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222035732/ownership.xml","form_type":"4"}},{"id":2084073,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71583,"kind":"person","name":"KOSKI ROBERT C","position":1,"cik":"0001234880","reported_name":"KOSKI ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-16T21:05:41.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":25000,"price":0.175,"value":4375.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The prices reported in Column 4 were the weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1700 to $0.1800 and $0.1600 to $0.1800 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares owned by the Koski Family Limited Partnership (\"KFLP\"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose."}],"balance_after":1285149,"source":{"system":"sec-edgar","filing":"0001493152-22-035732","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222035732/ownership.xml","form_type":"4"}},{"id":2085344,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71583,"kind":"person","name":"KOSKI ROBERT C","position":1,"cik":"0001234880","reported_name":"KOSKI ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-15T21:15:17.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":4503,"price":0.175,"value":788.025,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 was the weighted average price on the Transaction Date indicated. The shares were sold in multiple transactions ranging from $0.1700 to $0.1800 on the Transaction Date. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares owned by the Koski Family Limited Partnership (\"KFLP\"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose."}],"balance_after":1310149,"source":{"system":"sec-edgar","filing":"0001493152-22-035570","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222035570/ownership.xml","form_type":"4"}},{"id":2090014,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71583,"kind":"person","name":"KOSKI ROBERT C","position":1,"cik":"0001234880","reported_name":"KOSKI ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-12T21:22:59.000Z","date":"2022-12-09","kind":"sale","acquired":false,"shares":48795,"price":0.197,"value":9612.615,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 was the weighted average price on the Transaction Date indicated. The shares were sold in multiple transactions ranging from $0.1750 to $0.2000 on the Transaction Date. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares owned by the Koski Family Limited Partnership (\"KFLP\"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose."}],"balance_after":1314652,"source":{"system":"sec-edgar","filing":"0001493152-22-035184","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222035184/ownership.xml","form_type":"4"}},{"id":2091307,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71583,"kind":"person","name":"KOSKI ROBERT C","position":1,"cik":"0001234880","reported_name":"KOSKI ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-09T21:14:37.000Z","date":"2022-12-08","kind":"sale","acquired":false,"shares":13036,"price":0.2,"value":2607.2,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The prices reported in Column 4 are weighted average prices on the Transaction Date indicated. The shares were sold in multiple transactions ranging from $0.1901 to $0.2000 on the Transaction Date. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares owned by the Koski Family Limited Partnership (\"KFLP\"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose."}],"balance_after":1363447,"source":{"system":"sec-edgar","filing":"0001493152-22-035043","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222035043/ownership.xml","form_type":"4"}},{"id":2100236,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71583,"kind":"person","name":"KOSKI ROBERT C","position":1,"cik":"0001234880","reported_name":"KOSKI ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-01T21:08:52.000Z","date":"2022-11-30","kind":"sale","acquired":false,"shares":200000,"price":0.1911,"value":38220.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The prices reported in Column 4 are weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1900 to $0.2100 and $0.1800 to $0.2000 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares owned by the Koski Family Limited Partnership (\"KFLP\"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose."}],"balance_after":1376483,"source":{"system":"sec-edgar","filing":"0001493152-22-034167","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222034167/ownership.xml","form_type":"4"}},{"id":2100235,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71583,"kind":"person","name":"KOSKI ROBERT C","position":1,"cik":"0001234880","reported_name":"KOSKI ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-01T21:08:52.000Z","date":"2022-11-29","kind":"sale","acquired":false,"shares":200000,"price":0.1923,"value":38460.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The prices reported in Column 4 are weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1900 to $0.2100 and $0.1800 to $0.2000 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares owned by the Koski Family Limited Partnership (\"KFLP\"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose."}],"balance_after":1576483,"source":{"system":"sec-edgar","filing":"0001493152-22-034167","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222034167/ownership.xml","form_type":"4"}},{"id":2197969,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71583,"kind":"person","name":"KOSKI ROBERT C","position":1,"cik":"0001234880","reported_name":"KOSKI ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2022-08-02T20:42:11.000Z","date":"2022-07-29","kind":"grant","acquired":true,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022."}],"balance_after":220000,"derivative":{"exercise_price":0.3562,"exercise_date":"2022-07-29","expiration_date":"2032-07-29","underlying":"Common Stock","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0001493152-22-021024","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222021024/ownership.xml","form_type":"4"}},{"id":2197968,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":124988,"kind":"person","name":"Sullivan Michael O'Keefe","position":1,"cik":"0001542199","reported_name":"Sullivan Michael O'Keefe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-08-02T20:38:15.000Z","date":"2022-07-29","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, July 29, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, July 29, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, July 29, 2022."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, July 29, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, July 29, 2022."}],"balance_after":200000,"derivative":{"exercise_price":0.3562,"expiration_date":"2032-07-29","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-22-021018","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222021018/ownership.xml","form_type":"4"}},{"id":2197967,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2022-08-02T20:35:34.000Z","date":"2022-07-29","kind":"grant","acquired":true,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022."}],"balance_after":220000,"derivative":{"exercise_price":0.3562,"exercise_date":"2022-07-29","expiration_date":"2032-07-29","underlying":"Common Stock","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0001493152-22-021015","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222021015/ownership.xml","form_type":"4"}},{"id":2197966,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":26392,"kind":"person","name":"DUNTON ALAN W","position":1,"cik":"0001304773","reported_name":"DUNTON ALAN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2022-08-02T20:32:45.000Z","date":"2022-07-29","kind":"grant","acquired":true,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022."}],"balance_after":220000,"derivative":{"exercise_price":0.3562,"exercise_date":"2022-07-29","expiration_date":"2032-07-29","underlying":"Common Stock","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0001493152-22-021013","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222021013/ownership.xml","form_type":"4"}},{"id":2197981,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71592,"kind":"person","name":"POPE CHARLES L","position":1,"cik":"0001136354","reported_name":"POPE CHARLES L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2022-08-02T16:40:16.000Z","date":"2022-07-29","kind":"grant","acquired":true,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022."}],"balance_after":220000,"derivative":{"exercise_price":0.3562,"exercise_date":"2022-07-29","expiration_date":"2032-07-29","underlying":"Common Stock","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0001493152-22-021021","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136354/000149315222021021/ownership.xml","form_type":"4"}},{"id":2221401,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2022-06-27T20:10:15.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with service to the Company as Executive Chairman of the Board. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with service to the Company as Executive Chairman of the Board. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Due to a clerical error, the Form 4, as originally filed, incorrectly reported the option expiration date. The Form 4, as amended by this Form 4/A, correctly reports such information. No other changes have been made to the originally filed Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with service to the Company as Executive Chairman of the Board. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022."}],"balance_after":250000,"derivative":{"exercise_price":0.295,"exercise_date":"2022-06-23","expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001493152-22-017831","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222017831/ownership.xml","form_type":"4/A","original_submission_date":"2022-06-24"}},{"id":2222233,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":87344,"kind":"person","name":"Murphy Kimberly M","position":1,"cik":"0001810474","reported_name":"Murphy Kimberly M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Employee Option (Right to Buy)","published_at":"2022-06-24T20:15:32.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan in connection with the engagement to serve as the Company President and Chief Executive Officer. The options vest as follows: 160,000 options vest on the grant date, 160,000 options vest on December 23, 2022, 160,000 options vest on June 23, 2023, 160,000 options vest on December 23, 2023, and 160,000 options vest on June 23, 2024. The option exercise price is the Company's closing price on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan in connection with the engagement to serve as the Company President and Chief Executive Officer. The options vest as follows: 160,000 options vest on the grant date, 160,000 options vest on December 23, 2022, 160,000 options vest on June 23, 2023, 160,000 options vest on December 23, 2023, and 160,000 options vest on June 23, 2024. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":800000,"derivative":{"exercise_price":0.295,"exercise_date":"2022-06-23","expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001493152-22-017712","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222017712/ownership.xml","form_type":"4"}},{"id":2222232,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":124988,"kind":"person","name":"Sullivan Michael O'Keefe","position":1,"cik":"0001542199","reported_name":"Sullivan Michael O'Keefe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-06-24T20:15:28.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with interim service to the Company as Principal Executive Officer. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with interim service to the Company as Principal Executive Officer. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with interim service to the Company as Principal Executive Officer. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022."}],"balance_after":250000,"derivative":{"exercise_price":0.295,"exercise_date":"2022-06-23","expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001493152-22-017711","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222017711/ownership.xml","form_type":"4"}},{"id":2222231,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2022-06-24T20:15:23.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with service to the Company as Executive Chairman of the Board. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with service to the Company as Executive Chairman of the Board. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with service to the Company as Executive Chairman of the Board. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022."}],"balance_after":250000,"derivative":{"exercise_price":0.295,"exercise_date":"2022-06-23","expiration_date":"2022-06-23","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001493152-22-017710","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222017710/ownership.xml","form_type":"4"}},{"id":2225824,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-21T13:30:35.000Z","date":"2022-06-17","kind":"purchase","acquired":true,"shares":10084,"price":0.286,"value":2884.024,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased at an average price of $0.2860 on June 17, 2022. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":1010000,"source":{"system":"sec-edgar","filing":"0001493152-22-017293","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222017293/ownership.xml","form_type":"4"}},{"id":2256985,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-25T20:05:31.000Z","date":"2022-05-24","kind":"purchase","acquired":true,"shares":78673,"price":0.2895,"value":22775.8335,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging between $0.2800 and $0.3000 on May 24, 2022. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":999916,"source":{"system":"sec-edgar","filing":"0001493152-22-015040","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222015040/ownership.xml","form_type":"4"}},{"id":2256984,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-25T20:05:31.000Z","date":"2022-05-23","kind":"purchase","acquired":true,"shares":3500,"price":0.2869,"value":1004.15,"ownership":{"direct":true},"balance_after":921243,"source":{"system":"sec-edgar","filing":"0001493152-22-015040","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222015040/ownership.xml","form_type":"4"}},{"id":2260313,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-23T20:15:29.000Z","date":"2022-05-20","kind":"purchase","acquired":true,"shares":65718,"price":0.2836,"value":18637.6248,"ownership":{"direct":true},"balance_after":917743,"source":{"system":"sec-edgar","filing":"0001493152-22-014790","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222014790/ownership.xml","form_type":"4"}},{"id":2262196,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-20T20:15:26.000Z","date":"2022-05-19","kind":"purchase","acquired":true,"shares":56806,"price":0.2807,"value":15945.4442,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The prices reported in Column 4 are a weighted average prices. These shares were purchased in multiple transactions ranging between $0.2500 and $0.2700 on May 18, 2022 and between $0.2570 and $0.2998 on May 19, 2022. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":852025,"source":{"system":"sec-edgar","filing":"0001493152-22-014605","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222014605/ownership.xml","form_type":"4"}},{"id":2262195,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-20T20:15:26.000Z","date":"2022-05-18","kind":"purchase","acquired":true,"shares":15303,"price":0.261,"value":3994.083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The prices reported in Column 4 are a weighted average prices. These shares were purchased in multiple transactions ranging between $0.2500 and $0.2700 on May 18, 2022 and between $0.2570 and $0.2998 on May 19, 2022. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":795219,"source":{"system":"sec-edgar","filing":"0001493152-22-014605","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222014605/ownership.xml","form_type":"4"}},{"id":2311537,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-01T20:05:34.000Z","date":"2022-03-31","kind":"purchase","acquired":true,"shares":59053,"price":0.3517,"value":20768.9401,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The prices reported in Column 4 are a weighted average prices. These shares were purchased in multiple transactions ranging from $0.3510 to $0.3773 on March 30, 2022 and from $0.3407 to $0.3772 on March 31, 2022. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":779916,"source":{"system":"sec-edgar","filing":"0001493152-22-008799","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222008799/ownership.xml","form_type":"4"}},{"id":2311536,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-01T20:05:34.000Z","date":"2022-03-30","kind":"purchase","acquired":true,"shares":124785,"price":0.3629,"value":45284.4765,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The prices reported in Column 4 are a weighted average prices. These shares were purchased in multiple transactions ranging from $0.3510 to $0.3773 on March 30, 2022 and from $0.3407 to $0.3772 on March 31, 2022. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":720863,"source":{"system":"sec-edgar","filing":"0001493152-22-008799","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222008799/ownership.xml","form_type":"4"}},{"id":2314342,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":124988,"kind":"person","name":"Sullivan Michael O'Keefe","position":1,"cik":"0001542199","reported_name":"Sullivan Michael O'Keefe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim PEO, CFO"}}],"security":"Common Stock","published_at":"2022-03-30T18:41:07.000Z","date":"2022-03-29","kind":"purchase","acquired":true,"shares":20000,"price":0.3461,"value":6922.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.3456 to $0.3469. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":34255,"source":{"system":"sec-edgar","filing":"0001493152-22-008135","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222008135/ownership.xml","form_type":"4"}},{"id":2454643,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71583,"kind":"person","name":"KOSKI ROBERT C","position":1,"cik":"0001234880","reported_name":"KOSKI ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-03T21:29:06.000Z","date":"2021-12-31","kind":"purchase","acquired":true,"shares":799100,"price":0.474,"value":378773.4,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.44 to $0.48."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares owned by the Koski Family Limited Partnership (\"KFLP\"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose."}],"balance_after":1776483,"source":{"system":"sec-edgar","filing":"0001493152-22-000118","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222000118/ownership.xml","form_type":"4"}},{"id":2454642,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71583,"kind":"person","name":"KOSKI ROBERT C","position":1,"cik":"0001234880","reported_name":"KOSKI ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-03T21:29:06.000Z","date":"2021-12-30","kind":"purchase","acquired":true,"shares":200900,"price":0.4498,"value":90364.82,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.43 to $0.46. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares owned by the Koski Family Limited Partnership (\"KFLP\"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose."}],"balance_after":977383,"source":{"system":"sec-edgar","filing":"0001493152-22-000118","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222000118/ownership.xml","form_type":"4"}},{"id":2464204,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":87344,"kind":"person","name":"Murphy Kimberly M","position":1,"cik":"0001810474","reported_name":"Murphy Kimberly M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2021-12-20T21:10:27.000Z","date":"2021-12-16","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."}],"balance_after":75000,"derivative":{"exercise_price":0.49,"exercise_date":"2021-12-16","expiration_date":"2021-12-16","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-21-032033","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315221032033/ownership.xml","form_type":"4"}},{"id":2466817,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":124988,"kind":"person","name":"Sullivan Michael O'Keefe","position":1,"cik":"0001542199","reported_name":"Sullivan Michael O'Keefe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim PEO, CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-12-17T22:13:24.000Z","date":"2021-12-16","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, December 16, 2021."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, December 16, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, December 16, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, December 16, 2021."}],"balance_after":150000,"derivative":{"exercise_price":0.49,"expiration_date":"2031-12-16","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-21-031897","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315221031897/ownership.xml","form_type":"4"}},{"id":2466815,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71583,"kind":"person","name":"KOSKI ROBERT C","position":1,"cik":"0001234880","reported_name":"KOSKI ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2021-12-17T22:09:56.000Z","date":"2021-12-16","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."}],"balance_after":75000,"derivative":{"exercise_price":0.49,"exercise_date":"2021-12-16","expiration_date":"2031-12-16","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-21-031893","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315221031893/ownership.xml","form_type":"4"}},{"id":2466816,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2021-12-17T22:07:27.000Z","date":"2021-12-16","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."}],"balance_after":75000,"derivative":{"exercise_price":0.49,"exercise_date":"2021-12-16","expiration_date":"2031-12-16","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-21-031890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315221031890/ownership.xml","form_type":"4"}},{"id":2466814,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":26392,"kind":"person","name":"DUNTON ALAN W","position":1,"cik":"0001304773","reported_name":"DUNTON ALAN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2021-12-17T22:04:37.000Z","date":"2021-12-16","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."}],"balance_after":75000,"derivative":{"exercise_price":0.49,"exercise_date":"2021-12-16","expiration_date":"2031-12-16","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-21-031888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315221031888/ownership.xml","form_type":"4"}},{"id":2468061,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71592,"kind":"person","name":"POPE CHARLES L","position":1,"cik":"0001136354","reported_name":"POPE CHARLES L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2021-12-17T17:11:41.000Z","date":"2021-12-16","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."}],"balance_after":75000,"derivative":{"exercise_price":0.49,"exercise_date":"2021-12-16","expiration_date":"2031-12-16","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-21-031895","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136354/000149315221031895/ownership.xml","form_type":"4"}},{"id":2650550,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2021-06-30T20:06:01.000Z","date":"2021-06-29","kind":"exercise","acquired":false,"shares":156540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the exercise of a fully vested outstanding option award to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the exercise of a fully vested outstanding option award to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":0.48,"expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":156540},"source":{"system":"sec-edgar","filing":"0001493152-21-015714","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315221015714/ownership.xml","form_type":"4"}},{"id":2650549,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-30T20:06:01.000Z","date":"2021-06-29","kind":"exercise","acquired":true,"shares":156540,"price":0.48,"value":75139.2,"ownership":{"direct":true},"balance_after":596078,"source":{"system":"sec-edgar","filing":"0001493152-21-015714","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315221015714/ownership.xml","form_type":"4"}},{"id":2846583,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":87344,"kind":"person","name":"Murphy Kimberly M","position":1,"cik":"0001810474","reported_name":"Murphy Kimberly M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2021-02-19T21:37:03.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021."}],"balance_after":160000,"derivative":{"exercise_price":1.2,"exercise_date":"2021-02-18","expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001493152-21-004425","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315221004425/ownership.xml","form_type":"4"}},{"id":2846582,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":124988,"kind":"person","name":"Sullivan Michael O'Keefe","position":1,"cik":"0001542199","reported_name":"Sullivan Michael O'Keefe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-19T21:35:49.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 18, 2021."}],"balance_after":250000,"derivative":{"exercise_price":1.2,"expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001493152-21-004424","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315221004424/ownership.xml","form_type":"4"}},{"id":2846581,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":26392,"kind":"person","name":"DUNTON ALAN W","position":1,"cik":"0001304773","reported_name":"DUNTON ALAN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2021-02-19T21:35:37.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021."}],"balance_after":160000,"derivative":{"exercise_price":1.2,"exercise_date":"2021-02-18","expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001493152-21-004422","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315221004422/ownership.xml","form_type":"4"}},{"id":2846580,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71583,"kind":"person","name":"KOSKI ROBERT C","position":1,"cik":"0001234880","reported_name":"KOSKI ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2021-02-19T21:35:31.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares owned directly by Robert C. Koski, a director of the Company."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021."}],"balance_after":160000,"derivative":{"exercise_price":1.2,"exercise_date":"2021-02-18","expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001493152-21-004423","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315221004423/ownership.xml","form_type":"4"}},{"id":2846579,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71583,"kind":"person","name":"KOSKI ROBERT C","position":1,"cik":"0001234880","reported_name":"KOSKI ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T21:35:31.000Z","date":"2021-01-02","kind":"gift","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Shares owned directly by Robert C. Koski, a director of the Company."}],"balance_after":212839,"source":{"system":"sec-edgar","filing":"0001493152-21-004423","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315221004423/ownership.xml","form_type":"4"}},{"id":2846578,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":142438,"kind":"person","name":"Joslyn Alan","position":1,"cik":"0001294887","reported_name":"Joslyn Alan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-19T21:35:30.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 18, 2021."}],"balance_after":400000,"derivative":{"exercise_price":1.2,"expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001493152-21-004421","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315221004421/ownership.xml","form_type":"4"}},{"id":2846577,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2021-02-19T21:35:25.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021."}],"balance_after":160000,"derivative":{"exercise_price":1.2,"exercise_date":"2021-02-18","expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001493152-21-004420","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315221004420/ownership.xml","form_type":"4"}},{"id":2846661,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71592,"kind":"person","name":"POPE CHARLES L","position":1,"cik":"0001136354","reported_name":"POPE CHARLES L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2021-02-19T16:35:29.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021."}],"balance_after":160000,"derivative":{"exercise_price":1.2,"exercise_date":"2021-02-18","expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001493152-21-004419","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136354/000149315221004419/ownership.xml","form_type":"4"}},{"id":2895661,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $.001 par value","published_at":"2021-01-26T22:12:48.000Z","date":"2021-01-14","kind":"sale","acquired":false,"shares":870854,"price":0.9835,"value":856484.909,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person sold these shares of common stock on the open market."},{"field":"shares","element":"transactionShares","label":"F2","text":"On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This reflects the weighted average sale price. On January 14, 2021, the reporting person sold a total of 870,854 shares for a total of $859,466.01 on the open market, with the range of prices for such transactions being $0.9602 to $0.1.0068 per share. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-21-004433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000121390021004433/ownership.xml","form_type":"4"}},{"id":2895660,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $.001 par value","published_at":"2021-01-26T22:12:48.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":257510,"price":0.8,"value":206008.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person sold these shares of common stock on the open market."},{"field":"shares","element":"transactionShares","label":"F2","text":"On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"On January 13, 2021, the reporting person sold 257,510 shares on the open market at $0.8000 per share, the market price of the common stock on such date, for total proceeds of $205,994.44."}],"balance_after":870854,"source":{"system":"sec-edgar","filing":"0001213900-21-004433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000121390021004433/ownership.xml","form_type":"4"}},{"id":2895659,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $.001 par value","published_at":"2021-01-26T22:12:48.000Z","date":"2021-01-12","kind":"sale","acquired":false,"shares":629707,"price":0.7308,"value":460189.8756,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person sold these shares of common stock on the open market."},{"field":"shares","element":"transactionShares","label":"F2","text":"On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This reflects the weighted average sale price. On January 11, 2021, the reporting person sold a total of 629,707 shares for a total of $455,441.30 on the open market, with the range of prices for such transactions being $0.7201 to $0.7501 per share. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1128364,"source":{"system":"sec-edgar","filing":"0001213900-21-004433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000121390021004433/ownership.xml","form_type":"4"}},{"id":2895658,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $.001 par value","published_at":"2021-01-26T22:12:48.000Z","date":"2021-01-11","kind":"sale","acquired":false,"shares":441929,"price":0.771,"value":340727.259,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person sold these shares of common stock on the open market."},{"field":"shares","element":"transactionShares","label":"F2","text":"On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On January 11, 2021, the reporting person sold 441,929 shares on the open market at $0.7710 per share, the market price of the common stock on such date, for total proceeds of $340,710.72."}],"balance_after":1758071,"source":{"system":"sec-edgar","filing":"0001213900-21-004433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000121390021004433/ownership.xml","form_type":"4"}},{"id":2895657,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $.001 par value","published_at":"2021-01-26T22:12:48.000Z","date":"2021-01-07","kind":"sale","acquired":false,"shares":323997,"price":0.84,"value":272157.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person sold these shares of common stock on the open market."},{"field":"shares","element":"transactionShares","label":"F2","text":"On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On January 7, 2021, the reporting person sold 323,997 shares on the open market at $0.84 per share, the market price of the common stock on such date, for total proceeds of $272,157.48."}],"balance_after":2200000,"source":{"system":"sec-edgar","filing":"0001213900-21-004433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000121390021004433/ownership.xml","form_type":"4"}},{"id":2895656,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $.001 par value","published_at":"2021-01-26T22:12:48.000Z","date":"2021-01-06","kind":"sale","acquired":false,"shares":1000000,"price":0.6,"value":600000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person sold these shares of common stock on the open market."},{"field":"shares","element":"transactionShares","label":"F2","text":"On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This reflects the weighted average sale price. On January 6, 2021, the reporting person sold a total of 1,000,000 shares for a total of $645,000 on the open market, with the range of prices for such transactions being $0.60 to $0.73 per share. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2523997,"source":{"system":"sec-edgar","filing":"0001213900-21-004433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000121390021004433/ownership.xml","form_type":"4"}},{"id":2895655,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $.001 par value","published_at":"2021-01-26T22:12:48.000Z","date":"2021-01-05","kind":"sale","acquired":false,"shares":500000,"price":0.5804,"value":290200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person sold these shares of common stock on the open market."},{"field":"shares","element":"transactionShares","label":"F2","text":"On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On January 5, 2021, the reporting person sold 500,000 shares on the open market at $0.5804 per share, the market price of the common stock on such date, for total proceeds of $290,184.58."}],"balance_after":3523997,"source":{"system":"sec-edgar","filing":"0001213900-21-004433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000121390021004433/ownership.xml","form_type":"4"}},{"id":2895654,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $.001 par value","published_at":"2021-01-26T22:12:48.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":176003,"price":0.52,"value":91521.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person sold these shares of common stock on the open market."},{"field":"shares","element":"transactionShares","label":"F2","text":"On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On January 4, 2021, the reporting person sold 176,003 shares on the open market at $0.52 per share, the market price of the common stock on such date, for total proceeds of $91,521.56."}],"balance_after":4023997,"source":{"system":"sec-edgar","filing":"0001213900-21-004433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000121390021004433/ownership.xml","form_type":"4"}},{"id":2933329,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71583,"kind":"person","name":"KOSKI ROBERT C","position":1,"cik":"0001234880","reported_name":"KOSKI ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-23T23:15:25.000Z","date":"2020-12-22","kind":"sale","acquired":false,"shares":310000,"price":0.4272,"value":132432.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares owned by the Koski Family Limited Partnership (\"KFLP\"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose."}],"balance_after":776483,"source":{"system":"sec-edgar","filing":"0001493152-20-024267","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315220024267/ownership.xml","form_type":"4"}},{"id":2933328,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71583,"kind":"person","name":"KOSKI ROBERT C","position":1,"cik":"0001234880","reported_name":"KOSKI ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-23T23:15:25.000Z","date":"2020-04-24","kind":"gift","acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Shares owned directly by Robert C. Koski, a director of the Company."}],"balance_after":242839,"source":{"system":"sec-edgar","filing":"0001493152-20-024267","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315220024267/ownership.xml","form_type":"4"}},{"id":2955385,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $.001 par value","published_at":"2020-12-07T11:18:43.000Z","date":"2020-12-02","kind":"sale","acquired":false,"shares":5000000,"price":0.4103,"value":2051500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement. On December 2, 2020, the reporting person sold 5,000,000 of those shares on the open market at $0.4103 per share for total proceeds of $2,051,445.66, the market price of the common stock on such date."}],"balance_after":4200000,"source":{"system":"sec-edgar","filing":"0001213900-20-041200","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000121390020041200/ownership.xml","form_type":"4"}},{"id":2966389,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-25T21:05:35.000Z","date":"2020-11-24","kind":"purchase","acquired":true,"shares":100000,"price":0.37,"value":37000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents acquisition of shares of Common Stock through participation in the Company's underwritten public offering at the offering price per share of $0.37."}],"balance_after":439538,"source":{"system":"sec-edgar","filing":"0001493152-20-022545","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315220022545/ownership.xml","form_type":"4"}},{"id":3147502,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":142438,"kind":"person","name":"Joslyn Alan","position":1,"cik":"0001294887","reported_name":"Joslyn Alan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Series 1 Common Stock Warrants (right to buy)","published_at":"2020-05-15T20:30:50.000Z","date":"2020-05-14","kind":"other","acquired":true,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the expiration of an unexercised outstanding Warrant in accordance with its terms."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the expiration of an unexercised outstanding Warrant in accordance with its terms."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents the expiration of an unexercised outstanding Warrant in accordance with its terms."}],"balance_after":0,"derivative":{"exercise_price":0.75,"exercise_date":"2019-03-25","expiration_date":"2020-05-14","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001493152-20-009138","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315220009138/ownership.xml","form_type":"4"}},{"id":3147501,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series 1 Common Stock Warrants (right to buy)","published_at":"2020-05-15T20:30:47.000Z","date":"2020-05-14","kind":"other","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the expiration of an unexercised outstanding Warrant in accordance with its terms."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the expiration of an unexercised outstanding Warrant in accordance with its terms."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents the expiration of an unexercised outstanding Warrant in accordance with its terms."}],"balance_after":0,"derivative":{"exercise_price":0.75,"exercise_date":"2019-03-25","expiration_date":"2020-05-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-20-009137","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315220009137/ownership.xml","form_type":"4"}}],"next_cursor":"2020-05-15T20:30:47.000000Z,3147501"}